A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission

Condition:   Acute Myeloid Leukemia Interventions:   Drug: Idasanutlin;   Drug: Cytarabine;   Drug: Daunorubicin;   Procedure: Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials